Hu’s study indicated that the reduced expression of Mfn2 in DCM could be partly attributed to the result of reduced expression of peroxisome proliferator-activated receptor α (PPARα) (112). The gene discussed is MFN2; the disease is familial dilated cardiomyopathy.